239 related articles for article (PubMed ID: 23711673)
1. Examining structural violence in opioid pharmacotherapy treatment in Australia: sweating the "small stuff" in a liberal paradise.
Treloar C; Valentine K
Int J Drug Policy; 2013 Nov; 24(6):e11-3. PubMed ID: 23711673
[No Abstract] [Full Text] [Related]
2. The politics of providing opioid pharmacotherapy.
Radcliffe P; Parkes T
Int J Drug Policy; 2013 Nov; 24(6):e6-10. PubMed ID: 24183331
[No Abstract] [Full Text] [Related]
3. The role of the Chinese police in methadone maintenance therapy: a literature review.
Meng J; Burris S
Int J Drug Policy; 2013 Nov; 24(6):e25-34. PubMed ID: 23623719
[TBL] [Abstract][Full Text] [Related]
4. Opioid pharmacotherapy: Treatment, regimes, constructions and control.
Neale J
Int J Drug Policy; 2013 Nov; 24(6):e1-5. PubMed ID: 24075399
[No Abstract] [Full Text] [Related]
5. From political controversy to a technical problem? Fifteen years of opioid substitution treatment in Finland.
Selin J; Hakkarainen P; Partanen A; Tammi T; Tigerstedt C
Int J Drug Policy; 2013 Nov; 24(6):e66-72. PubMed ID: 24095679
[TBL] [Abstract][Full Text] [Related]
6. Zoned Out: "NIMBYism", addiction services and municipal governance in British Columbia.
Bernstein SE; Bennett D
Int J Drug Policy; 2013 Nov; 24(6):e61-5. PubMed ID: 23680227
[TBL] [Abstract][Full Text] [Related]
7. Methadone, a contested substance: Danish methadone policy in the 1970s.
Houborg E
Int J Drug Policy; 2013 Nov; 24(6):e73-80. PubMed ID: 24120441
[TBL] [Abstract][Full Text] [Related]
8. Work and the journey to recovery: exploring the implications of welfare reform for methadone maintenance clients.
Monaghan M; Wincup E
Int J Drug Policy; 2013 Nov; 24(6):e81-6. PubMed ID: 24360401
[TBL] [Abstract][Full Text] [Related]
9. Shouting through bullet-proof glass: some reflections on pharmacotherapy provision in one Australian clinic.
Crawford S
Int J Drug Policy; 2013 Nov; 24(6):e14-7. PubMed ID: 24007689
[TBL] [Abstract][Full Text] [Related]
10. Sameness and difference: metaphor and politics in the constitution of addiction, social exclusion and gender in Australian and Swedish drug policy.
Moore D; Fraser S; Törrönen J; Tinghög ME
Int J Drug Policy; 2015 Apr; 26(4):420-8. PubMed ID: 25662895
[TBL] [Abstract][Full Text] [Related]
11. The disparate treatment of medications and opiate pain medications under the law: permitting the proliferation of opiates and limiting access to treatment.
Ferrara MM
Seton Hall Law Rev; 2012; 42(2):741-67. PubMed ID: 22708140
[No Abstract] [Full Text] [Related]
12. Non-prescribed use of substitution medication among German drug users--prevalence, motives and availability.
Schmidt CS; Schulte B; Wickert C; Thane K; Kuhn S; Verthein U; Reimer J
Int J Drug Policy; 2013 Nov; 24(6):e111-4. PubMed ID: 23726899
[No Abstract] [Full Text] [Related]
13. Substance, structure and stigma: parents in the UK accounting for opioid substitution therapy during the antenatal and postnatal periods.
Chandler A; Whittaker A; Cunningham-Burley S; Williams N; McGorm K; Mathews G
Int J Drug Policy; 2013 Nov; 24(6):e35-42. PubMed ID: 23688832
[TBL] [Abstract][Full Text] [Related]
14. At least 80 people have died in Crimea since Russian law banned opioid substitutes, says UN special envoy.
Hurley R
BMJ; 2015 Jan; 350():h390. PubMed ID: 25608514
[No Abstract] [Full Text] [Related]
15. Increasing access to opioid maintenance treatment: the role of primary care in France.
Roux P; Lions C; Carrieri MP
Int J Drug Policy; 2015 Apr; 26(4):434-5. PubMed ID: 25683137
[No Abstract] [Full Text] [Related]
16. Palliative care in India suffers due to cumbersome rules.
Sharma DC
Lancet Oncol; 2014 Feb; 15(2):e54. PubMed ID: 24627907
[No Abstract] [Full Text] [Related]
17. Drug effects, performativity and the law.
Race K
Int J Drug Policy; 2011 Nov; 22(6):410-2. PubMed ID: 22056290
[No Abstract] [Full Text] [Related]
18. Toward safe accessibility of opioid pain medicines in Vietnam and other developing countries: a balanced policy method.
Krakauer EL; Nguyen TP; Husain SA; Nguyen TH; Joranson DE; Luong NK; Maurer MA
J Pain Symptom Manage; 2015 May; 49(5):916-22. PubMed ID: 25523889
[TBL] [Abstract][Full Text] [Related]
19. 'Opioid drought', Canadian-style? Potential implications of the 'natural experiment' of delisting oxycontin in Canada.
Fischer B; Keates A
Int J Drug Policy; 2012 Nov; 23(6):495-7. PubMed ID: 22940141
[No Abstract] [Full Text] [Related]
20. Studying up harm reduction policy: the office as an assemblage.
Chen JS
Int J Drug Policy; 2011 Nov; 22(6):471-7. PubMed ID: 22000601
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
